Clinical trials

Clinical trials

The FPI work with a number of pharmaceutical companies on current and potential future clinical trials.

Current trials

  • Alector AL001 Phase 2 trial for GRN mutation carriers – recruiting at a number of FPI centres [UCL, Erasmus, Toronto, London Ontario, Brescia, Ulm, Paris].

Companies with therapies for genetic FTD in development